Health ❯ Healthcare ❯ Immunotherapy

Cancer Immunotherapy

Immune-Independent Therapies Neoantigens HER2 Positive Breast Cancer mRNA-based Immunotherapy Tumor-Associated Macrophages Nivolumab KRAS-targeted Therapies Vaccine Development MHC Class II Targeted Therapy Pancreatic Cancer Intratumoral Therapy Nanoinmunotherapy Neoantigen Vaccines T-cell Infiltration

KRAS Vaccine Safely Triggers Lasting Immune Response in People at High Risk for Pancreatic Cancer

The small phase 1 trial shows durable KRAS-specific T cells after vaccination with clinical prevention still unproven.

Triple Therapy Counters Endocrine Resistance in ER+ Breast Cancer in Preclinical Study

Off-The-Shelf KRAS Vaccine Yields Robust T-Cell Responses and Survival Benefit

Pre-Surgery Nivolumab and Chemotherapy Improve Five-Year Survival in Operable Lung Cancer